Su-Lin Lee

Su-Lin Lee, Ph.D., RAC, is a seasoned professional in regulatory affairs and chemistry, currently serving as Director of Regulatory Affairs CMC at Pacira BioSciences, Inc. Since October 2024. Su-Lin's prior experience includes positions such as Senior Manager Regulatory CMC at Bristol Myers Squibb and Mirati Therapeutics, where responsibilities involved managing CMC regulatory strategies and submissions for clinical and commercial drug products. Su-Lin's regulatory expertise was further developed during a tenure as CMC Reviewer at the FDA Office of New Drug Products, where comprehensive assessments of various regulatory submissions were conducted. Su-Lin holds a Ph.D. in Medicinal Chemistry from The Ohio State University and advanced degrees in Pharmacy and Chemistry from National Taiwan University and National Chung Cheng University, respectively.